Ark Genomic Revolution UCITS ETF (LON:ARKG)
9.75
-0.12 (-1.17%)
Sep 23, 2026, 2:43 PM GMT
LON:ARKG Holdings Information
LON:ARKG is an equity ETF with a total of 32 individual holdings. The top holdings are Twist Bioscience stock at 9.72%, Tempus AI at 9.22%, 10x Genomics at 7.41%, CRISPR Therapeutics AG at 5.53%, and Absci at 4.89%.
Total Holdings
32
Top 10 Percentage
58.93%
Asset Class
Equity
ETF Category
Theme
Assets
81.92M
PE Ratio
n/a
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | TWST | Twist Bioscience Corporation | 9.72% |
| 2 | TEM | Tempus AI, Inc. | 9.22% |
| 3 | TXG | 10x Genomics, Inc. | 7.41% |
| 4 | CRSP | CRISPR Therapeutics AG | 5.53% |
| 5 | ABSI | Absci Corporation | 4.89% |
| 6 | NTRA | Natera, Inc. | 4.61% |
| 7 | CDNA | CareDx, Inc. | 4.61% |
| 8 | ILMN | Illumina, Inc. | 4.50% |
| 9 | PSNL | Personalis, Inc. | 4.46% |
| 10 | LLY | Eli Lilly and Company | 3.98% |
| 11 | CMPS | COMPASS Pathways plc | 3.61% |
| 12 | GH | Guardant Health, Inc. | 3.14% |
| 13 | BEAM | Beam Therapeutics Inc. | 3.04% |
| 14 | SDGR | Schrödinger, Inc. | 2.91% |
| 15 | RXRX | Recursion Pharmaceuticals, Inc. | 2.77% |
| 16 | NTLA | Intellia Therapeutics, Inc. | 2.76% |
| 17 | WGS | GeneDx Holdings Corp. | 2.44% |
| 18 | NRIX | Nurix Therapeutics, Inc. | 2.35% |
| 19 | BFLY | Butterfly Network, Inc. | 2.13% |
| 20 | VCYT | Veracyte, Inc. | 2.04% |
| 21 | ADPT | Adaptive Biotechnologies Corporation | 1.97% |
| 22 | ARCT | Arcturus Therapeutics Holdings Inc. | 1.91% |
| 23 | ALMR | Alamar Biosciences, Inc. | 1.74% |
| 24 | IONS | Ionis Pharmaceuticals, Inc. | 1.58% |
| 25 | GENB | Generate Biomedicines, Inc. | 1.25% |
As of Sep 21, 2026